Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment improves chronic tendinopathy, and imaging biomarkers can track tendon changes.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Frunevetmab injections in cats can cause severe itching and skin lesions.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Upadacitinib effectively treats pyoderma gangrenosum.

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Sorafenib can cause rare skin reactions, but treatment can continue with additional care.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Tofacitinib may help treat severe hair loss, but more research is needed.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.